KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $7.69.

  • Quest Diagnostics' EPS (Weighted Average and Diluted) rose 8.54% to $2.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.52, marking a year-over-year increase of 14.52%. This contributed to the annual value of $7.69 for FY2024, which is 2.67% up from last year.
  • Quest Diagnostics' EPS (Weighted Average and Diluted) amounted to $7.69 in FY2024, which was up 2.67% from $7.49 recorded in FY2023.
  • Quest Diagnostics' 5-year EPS (Weighted Average and Diluted) high stood at $15.55 for FY2021, and its period low was $7.49 during FY2023.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $7.69 (2024), whereas its average is $7.72.
  • As far as peak fluctuations go, Quest Diagnostics' EPS (Weighted Average and Diluted) soared by 66.72% in 2020, and later tumbled by 48.75% in 2022.
  • Quest Diagnostics' EPS (Weighted Average and Diluted) (Yearly) stood at $10.47 in 2020, then spiked by 48.52% to $15.55 in 2021, then tumbled by 48.75% to $7.97 in 2022, then declined by 6.02% to $7.49 in 2023, then increased by 2.67% to $7.69 in 2024.